Literature DB >> 12672554

The influence of adenosine A3 receptor agonist: IB-MECA, on scopolamine- and MK-801-induced memory impairment.

Andrzej Rubaj1, Witold Zgodziński, Maria Sieklucka-Dziuba.   

Abstract

The effects of adenosine A3 agonist IB-MECA on scopolamine- and MK-801-induced impairment of spontaneous alternation and learning abilities were examined using Y-maze and passive avoidance tasks in mice. IB-MECA given 20 min before test had no effect on spontaneous alternation performance. Similarly learning abilities tested in passive avoidance were not disturbed after IB-MECA administration before training session. IB-MECA significantly diminished scopolamine- and MK-801-induced impairment of spontaneous alternation in Y-maze and learning abilities in passive avoidance task as well as reduced higher locomotor activity in MK-801-treated group. This ameliorating effect of IB-MECA was not antagonised by adenosine A1 antagonists CPX. Obtained results indicate that adenosine A3 receptor stimulation may ameliorate spatial memory and long term memory impairments in terms of cholinergic and glutamatergic deficits induced by scopolamine and MK-801, respectively.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12672554     DOI: 10.1016/s0166-4328(02)00314-5

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  11 in total

1.  Adenosine A(1) receptor: Functional receptor-receptor interactions in the brain.

Authors:  Kathrin Sichardt; Karen Nieber
Journal:  Purinergic Signal       Date:  2007-09-05       Impact factor: 3.765

2.  Role of nitric oxide in the behavioral and neurochemical effects of IB-MECA in zebrafish.

Authors:  Caio Maximino; Julliany Gemaque; Rancés Benzecry; Monica Gomes Lima; Evander de Jesus Oliveira Batista; Domingos Wanderley Picanço-Diniz; Karen Renata Matos Oliveira; Anderson Manoel Herculano
Journal:  Psychopharmacology (Berl)       Date:  2014-11-13       Impact factor: 4.530

3.  Controlling murine and rat chronic pain through A3 adenosine receptor activation.

Authors:  Zhoumou Chen; Kali Janes; Collin Chen; Tim Doyle; Leesa Bryant; Dilip K Tosh; Kenneth A Jacobson; Daniela Salvemini
Journal:  FASEB J       Date:  2012-02-17       Impact factor: 5.191

4.  (N)-methanocarba 2,N6-disubstituted adenine nucleosides as highly potent and selective A3 adenosine receptor agonists.

Authors:  Susanna Tchilibon; Bhalchandra V Joshi; Soo-Kyung Kim; Heng T Duong; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2005-03-24       Impact factor: 7.446

5.  The A3 adenosine receptor attenuates the calcium rise triggered by NMDA receptors in retinal ganglion cells.

Authors:  Mei Zhang; Huiling Hu; Xiulan Zhang; Wennan Lu; Jason Lim; Thor Eysteinsson; Kenneth A Jacobson; Alan M Laties; Claire H Mitchell
Journal:  Neurochem Int       Date:  2009-08-31       Impact factor: 3.921

6.  In vivo investigation of the neuroprotective property of Convolvulus pluricaulis in scopolamine-induced cognitive impairments in Wistar rats.

Authors:  Syed Waseem Bihaqi; Avninder Pal Singh; Manisha Tiwari
Journal:  Indian J Pharmacol       Date:  2011-09       Impact factor: 1.200

7.  COGNITIVE-ENHANCING PROPERTIES OF MORINDA LUCIDA (RUBIACEAE) AND PELTOPHORUM PTEROCARPUM (FABACEAE) IN SCOPOLAMINE-INDUCED AMNESIC MICE.

Authors:  Elufioye Taiwo O; Hameed Halimah A
Journal:  Afr J Tradit Complement Altern Med       Date:  2017-03-01

8.  Phytoceramide shows neuroprotection and ameliorates scopolamine-induced memory impairment.

Authors:  Jae-Chul Jung; Yeonju Lee; Sohyeon Moon; Jong Hoon Ryu; Seikwan Oh
Journal:  Molecules       Date:  2011-10-28       Impact factor: 4.411

9.  Olive leaf extract prevents obesity, cognitive decline, and depression and improves exercise capacity in mice.

Authors:  Toshio Mikami; Jimmy Kim; Jonghyuk Park; Hyowon Lee; Pongson Yaicharoen; Sofya Suidasari; Miki Yokozawa; Ken Yamauchi
Journal:  Sci Rep       Date:  2021-06-14       Impact factor: 4.379

Review 10.  Exploration of chalcones and related heterocycle compounds as ligands of adenosine receptors: therapeutics development.

Authors:  Chrisna Matthee; Gisella Terre'Blanche; Lesetja J Legoabe; Helena D Janse van Rensburg
Journal:  Mol Divers       Date:  2021-06-27       Impact factor: 3.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.